Published in Vaccine Weekly, August 17th, 2011
Last month, the CDC concluded a four-city public meeting tour to gather input on whether or not it should add FDA-approved meningitis vaccines to the existing recommended immunization schedule. While nearly 70 percent (69.75%) of all the regional hearing participants voted in favor of adding...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly